Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds, the development of a full range of natural healthcare products, and innovative mental health treatment, is pleased to announce a product listing agreement for a range of Havn Life's natural health products,…
Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"), a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, and innovative mental health treatment to support brain health and enhance the capabilities of the mind, is pleased to announce it has signed a…
Havn Life Sciences Inc. (CNSX:HAVN) (FRA:5NP), a biotechnology company focused on unlocking human potential using evidence-informed research and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce its initial seven natural health supplements. These 7 products will be Havn Life's first natural health products to launch…
Last month, Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) commenced trading on the Canadian Stock Exchange (CSE) and is an opportunity that we have been closely following. We consider Havn Life to be an attractive play on the burgeoning psychedelic therapy market and believe that the opportunity is flying under the…
Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP), a biotechnology company focused on unlocking human potential using evidence-informed research and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce it has signed an agreement to supply Revive Therapeutics Ltd. (CSE:RVV, USA:RVVTF) with psychedelic compounds for use in investigational new drug…
Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life") is pleased to announce that Mr. Vic Neufeld has been appointed as the Chairman of the Board of Directors of the Company (the "Board"). Mr. Neufeld brings a wealth of knowledge and experience in the Natural Health Food industry, having served…
Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce that it has joined the Drug Science Medical Psychedelics Working Group consortium. The working group was…
Last week, Havn Life Sciences Inc. (CSE:HAVN) commenced trading on the Canadian Securities Exchange (CSE) under the ticker symbol HAVN. The biotech company has been focused on the development of standardized psychoactive compounds that are derived from plants and fungi for use in research and is an opportunity that we…
Havn Life Sciences Inc. (CSE:HAVN), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce that it has commenced trading on the Canadian Securities Exchange ("CSE") under the ticker symbol "HAVN". "Listing on the Canadian…
We have seen a substantial increase in interest in psychedelic focused businesses during the last month and this is a trend that our readers need to be aware of. The psychedelic sector has recently come under pressure and we encourage our readers to conduct significant due diligence on companies in…
